CRP and breast carcinoma: Table 2 provides a summary of findings for the association of CRP with breast cancer risk from the three meta-analyses and 12 unique studies, subdivided into the eight different cohorts assessed (three studies used data from the Women’s Health Initiative (WHI) but considered different stratification groups [28,32,34], and two studies used data from the Women’s Health Study (WHS) [21,35]).